POMDOCTOR Limited issued 33,185,841 Class A ordinary shares at a conversion price of US$0.452 per share to satisfy RMB100,053,000 (US$15 million) of indebtedness owed by its PRC operating subsidiary to Chairman and CEO Zhenyang Shi. The transaction was approved by disinterested directors and completed on November 4, 2026, with shares issued offshore under Regulation S. The company operates in the digital health and medical technology sector.
